Literature DB >> 18392663

Sex hormones, their receptors and bone health.

K Venken1, F Callewaert, S Boonen, D Vanderschueren.   

Abstract

Sex steroids regulate skeletal maturation and preservation in both men and women, as already recognized in the 1940s by Albright and Reifenstein. The impact of gonadal insufficiency on skeletal integrity has been widely recognized in adult men and women ever since. In the context of their skeletal actions, androgens and estrogens are no longer considered as just male and female hormones, respectively. Androgens can be converted into estrogens within the gonads and peripheral tissues and both are present in men and women, albeit in different concentrations. In the late 1980s, sex steroid receptors were discovered in bone cells. However, the understanding of sex steroid receptor activation and translation into biological skeletal actions is still incomplete. Due to the complex metabolism, sex steroids may have not only endocrine but also paracrine and/or autocrine actions. Also, circulating sex steroid concentrations do not necessarily reflect their biological activity due to strong binding to sex hormone binding globulin (SHBG). Finally, sex steroid signaling may include genomic and non-genomic effects in bone and non-bone cells. This review will focus on our current understanding of gonadal steroid metabolism, receptor activation, and their most relevant cellular and biological actions on bone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392663     DOI: 10.1007/s00198-008-0609-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  78 in total

Review 1.  Nuclear receptor coregulators: cellular and molecular biology.

Authors:  N J McKenna; R B Lanz; B W O'Malley
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

3.  Identification of the classical androgen receptor in male rat liver and prostate cell plasma membranes.

Authors:  E F Konoplya; E H Popoff
Journal:  Int J Biochem       Date:  1992-12

Review 4.  From density to structure: growing up and growing old on the surfaces of bone.

Authors:  E Seeman
Journal:  J Bone Miner Res       Date:  1997-04       Impact factor: 6.741

Review 5.  The role of 5alpha-reduction in steroid hormone physiology.

Authors:  J D Wilson
Journal:  Reprod Fertil Dev       Date:  2001       Impact factor: 2.311

6.  Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.

Authors:  Sara H Windahl; René Galien; Riccardo Chiusaroli; Philippe Clément-Lacroix; Frederic Morvan; Liên Lepescheux; François Nique; William C Horne; Michèle Resche-Rigon; Roland Baron
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 7.  Aromatase activity and bone homeostasis in men.

Authors:  Luigi Gennari; Ranuccio Nuti; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 8.  Nongenomic steroid action: controversies, questions, and answers.

Authors:  Ralf M Losel; Elisabeth Falkenstein; Martin Feuring; Armin Schultz; Hanns-Christian Tillmann; Karin Rossol-Haseroth; Martin Wehling
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Authors:  Marielle H Emmelot-Vonk; Harald J J Verhaar; Hamid R Nakhai Pour; André Aleman; Tycho M T W Lock; J L H Ruud Bosch; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  JAMA       Date:  2008-01-02       Impact factor: 56.272

10.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

View more
  21 in total

1.  The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin.

Authors:  Anna Gajos-Michniewicz; Elzbieta Pawlowska; Tomasz Ochedalski; Agnieszka Piastowska-Ciesielska
Journal:  J Bone Miner Metab       Date:  2012-02-07       Impact factor: 2.626

2.  Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-05       Impact factor: 3.478

3.  Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Susan L Greenspan; Donna King; Amir Hamrahian; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

Review 4.  Testicular function and bone metabolism--beyond testosterone.

Authors:  Alberto Ferlin; Riccardo Selice; Umberto Carraro; Carlo Foresta
Journal:  Nat Rev Endocrinol       Date:  2013-07-16       Impact factor: 43.330

5.  Reexamining the Surfaces of Bone in Boys and Girls During Adolescent Growth: A 12-Year Mixed Longitudinal pQCT Study.

Authors:  Leigh Gabel; Lindsay Nettlefold; Penelope M Brasher; Sarah A Moore; Yasmin Ahamed; Heather M Macdonald; Heather A McKay
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

6.  Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells.

Authors:  S Benvenuti; I Cellai; P Luciani; C Deledda; R Saccardi; B Mazzanti; S Dal Pozzo; M Serio; A Peri
Journal:  J Endocrinol Invest       Date:  2011-05-19       Impact factor: 4.256

7.  Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis.

Authors:  Marzia Ferretti; Laura Bertoni; Francesco Cavani; Manuela Zavatti; Elisa Resca; Gianluca Carnevale; Augusta Benelli; Paola Zanoli; Carla Palumbo
Journal:  J Anat       Date:  2010-05-10       Impact factor: 2.610

8.  Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.

Authors:  Benjamin Z Leder; Robert M Neer; Jason J Wyland; Hang W Lee; Sherri-Ann M Burnett-Bowie; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2009-05-12       Impact factor: 5.958

Review 9.  Bone and skeletal muscle: neighbors with close ties.

Authors:  Douglas J DiGirolamo; Douglas P Kiel; Karyn A Esser
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

Review 10.  Vitamin D interactions with soy isoflavones on bone after menopause: a review.

Authors:  Clara Y Park; Connie M Weaver
Journal:  Nutrients       Date:  2012-11-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.